Surgery Partners Inc. (SGRY)
NASDAQ: SGRYHealth CareHospital/Nursing ManagementUSD
At close: Nov 20, 4:00 PM ET · Delayed 15 min
SGRY stock chart
Technical analysisKey statistics
All statistics- Market cap
- $3.50B
- Forward P/E
- 88.39
- EPS (TTM)
- -$0.67
- Dividend yield
- None
- 52-week range
- 11.41 – 27.23
- Day range
- 26.64 – 26.96
- Volume / Avg
- 1.11M / 3.87M
- Beta
- —
- Shares outstanding
- 130.88M
52-week range
SGRY stock today
Surgery Partners (SGRY) closed at $26.78 on Nov 20, up 0.34% (+$0.09), versus the S&P 500's 3.70% decline. Trading was light, with 1.11M shares changing hands, about 29% of the average daily volume. Shares are 1.6% below their 52-week high of $27.23, set on Nov 9, 2026 and 134.7% above the 52-week low of $11.41, near the top of the past year's range.
SGRY is up 73.3% year to date, outperforming the S&P 500 (+1.2%). Over the past 12 months, the stock has gained 69.1%. Surgery Partners has posted a net loss over the last twelve months (EPS of -$0.67), so its P/E ratio is not meaningful.
Summary generated from market data by MetaCap's automated system. Methodology
About Surgery Partners
Company profileSurgery Partners, Inc., together with its subsidiaries, owns and operates a network of surgical facilities and ancillary services in the United States. The company provides ambulatory surgery centers and surgical hospitals that offer non-emergency surgical procedures in various specialties, including orthopedics and pain management, ophthalmology, gastroenterology, and general surgery. It offers emergency departments; ancillary services such as physician practices and diagnostic testing; multi-specialty physician practices; urgent care facilities; and anesthesia services.
- Sector
- Health Care
- Industry
- Hospital/Nursing Management
- CEO
- Mr. J. Eric Evans
- Headquarters
- Brentwood, TN
- Employees
- 16,000
- IPO year
- 2015
- Website
- surgerypartners.com
Financial highlights
Full financialsIn fiscal 2025, Surgery Partners generated $3.31 billion in revenue, up 6.2% from fiscal 2024, its 11th consecutive year of revenue growth. Surgery Partners reported a net loss of $77.9 million, compared with a loss of $168.1 million a year earlier. Operating margin was 11.8%.
| Fiscal year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
| Revenue | $3.31B | $3.11B | $2.74B | $2.54B | $2.23B |
| Growth | +6.24% | +13.52% | +8.03% | +14.12% | +19.62% |
| Net income | $-77.90M | $-168.10M | $-11.90M | $-54.60M | $-70.90M |
| EPS (diluted) | $-0.61 | $-1.33 | $-0.09 | $-0.59 | $-1.12 |
Analyst forecast
ForecastConsensus (7 analysts)
hold
Avg. price target
$24.40-8.89%
- Strong buy 0
- Buy 0
- Hold 7
- Sell 0
- Strong sell 0
Target range
Ratings and targets reflect third-party analyst opinions, not MetaCap recommendations.
Earnings
Earnings history- Last reported (Sep/2026)
- Nov 9, 2026
- EPS actual vs est.
- $-0.16 vs $-0.13
- Surprise
- -23.08%
SGRY news
All SGRY news- Surgery Partners, Inc. Announces Expiration and Results of Consent Solicitation Relating to Surgery Center Holdings, Inc.’s 7.250% Senior Notes due 2032GlobeNewswire
- SGRY Stock Alert: Halper Sadeh LLC is Investigating Whether Surgery Partners, Inc. is Obtaining a Fair Price for its ShareholdersPR Newswire
- SGRY Shareholders: Amparo Law Firm PLLC Is Investigating Whether Surgery Partners's $23.50-Per-Share Sale to HealthSpan Partners Delivers the Best Value for ShareholdersGlobeNewswire
- Surgery Partners, Inc. Announces Increased Consent Fee in Consent Solicitation Relating to Surgery Center Holdings, Inc.’s 7.250% Senior Notes due 2032GlobeNewswire
- SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Stockholders of an Investigation into the Fairness of the Acquisition of Surgery Partners, Inc. (SGRY)PR Newswire
- Surgery Partners, Inc. Announces Consent Solicitation for 7.250% Senior Notes due 2032Nasdaq
- Surgery Partners' Q3 Loss Narrows To $21 Mln; HealthSpan Merger Worth $6 Bln To Close In Q1 '27NasdaqSGRY, LEN.B
- Surgery Partners, Inc. Amends HealthSpan Partners Merger Agreement to $25.00 Per Share and Reports Third Quarter 2026 ResultsNasdaq
Surgery Partners peers
Health Care sector| Company | Price | % Chg | Market cap | Compare |
|---|---|---|---|---|
| NHCNational HealthCare Corporation | 190.77 | +1.18% | $2.99B | vs SGRY |
| MDPediatrix Medical Group Inc. | 30.22 | +0.94% | $2.36B | vs SGRY |
| BKDBrookdale Senior Living Inc. | 8.86 | +1.96% | $2.12B | vs SGRY |
| ARDTArdent Health Inc. | 15.08 | +4.00% | $2.10B | vs SGRY |
| HCSGHealthcare Services Group Inc. | 24.72 | -0.20% | $1.67B | vs SGRY |
| SNDASonida Senior Living Inc. | 31.47 | -0.57% | $1.55B | vs SGRY |
| CYHCommunity Health Systems Inc. | 1.62 | +0.62% | $228.46M | vs SGRY |
| PACSPACS Group Inc. | 43.67 | +1.49% | $6.93B | vs SGRY |
Indexes, lists and sector
Surgery Partners stock FAQ
What is Surgery Partners's stock price today?
SGRY last traded at $26.78 as of Nov 20, 4:00 PM EST, up 0.34% on the day. Prices are delayed at least 15 minutes.
Who is Surgery Partners's CEO?
Mr. J. Eric Evans is the chief executive officer of Surgery Partners Inc., which has about 16,000 employees.
What is the SGRY 52-week high?
The 52-week high for SGRY is $27.23 and the 52-week low is $11.41. The stock is currently 1.6% below its high.